SCHEMBL507694

SCHEMBL507694

CCCCN1C=CN(C)C1OC(=O)CCC

nearest known ligand 0.35

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.34
NAAA Q02083 2/20 0.34
CES2 O00748 1/20 0.31
CES1 P23141 1/20 0.31
BCHE P06276 1/20 0.30
TP53 P04637 1/20 0.30
POLB P06746 1/20 0.30
MAPT P10636 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL446968 0.95 NAAA (0.38) NAAACES2CES1BCHETP53
SCHEMBL3125483 0.91 NAAA (0.45) NAAAMAPT
SCHEMBL357675 0.90 NAAA (0.32) NAAACES1
SCHEMBL358645 0.89 NAAA (0.33) ALDH1A1NAAATP53MAPT
SCHEMBL17418659 0.87 NAAA (0.31) NAAA
SCHEMBL28434854 0.86
SCHEMBL5032087 0.85 OGA (0.33) ALDH1A1CES2CES1
SCHEMBL17418403 0.85
SCHEMBL35017 0.84 ALDH1A1 (0.33) ALDH1A1CES1
SCHEMBL17418643 0.84 ABCB11 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 95 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12421350-B2 Process of preparing a poly(anthranilide), poly(anthranilide) and its use COVESTRO DEUTSCHLAND AG (DE) 2025-09-23 US claimed
US-20230257523-A1 METHOD FOR PRODUCING A POLY(ANTHRANILAMIDE), POLY(ANTHRANILAMIDE) AND USE THEREOF COVESTRO DEUTSCHLAND AG (DE) 2023-08-17 US claimed
US-20230235120-A1 PROCESS OF PREPARING A POLY(ANTHRANILIDE), POLY(ANTHRANILIDE) AND ITS USE COVESTRO DEUTSCHLAND AG (DE) 2023-07-27 US claimed
EP-4179005-A1 PROCESS OF PREPARING A POLY(ANTHRANILAMIDE), POLY(ANTHRANILAMIDE) AND ITS USE Covestro Deutschland AG (DE) 2023-05-17 EP claimed
EP-4179004-A1 METHOD FOR PRODUCING A POLY(ANTHRANILAMIDE), POLY(ANTHRANILAMIDE) AND USE THEREOF Covestro Deutschland AG (DE) 2023-05-17 EP claimed
CN-115996969-A Method for producing poly (anthranilamide), poly (anthranilamide) and use thereof 科思创德国股份有限公司 2023-04-21 CN claimed
CN-115768815-A Method for producing poly (anthranilamides), poly (anthranilamides) and use thereof 科思创德国股份有限公司 2023-03-07 CN claimed
CN-109988449-A A method of preparing titanium dioxide/cenosphere complex reflex thermal insulating filling 中国石油化工股份有限公司 2019-07-09 CN claimed
CN-103193964-B A kind of preparation method of cellulose ester grafted aliphatic polyester multipolymer INSTITUTE OF CHEMISTRY, CHINESE ACADEMY OF SCIENCES (CN) 2015-08-19 CN claimed
CN-102936762-B Preparation method of chitosan/cellulose homogeneous spinning solution CHINA TEXTILE ACADEMY 2015-04-08 CN claimed
US-7919631-B2 Production of ionic liquids EASTMAN CHEMICAL COMPANY (US) 2011-04-05 US claimed
EP-2121766-A1 CELLULOSE ESTERS AND THEIR PRODUCTION IN CARBOXYLATED IONIC LIQUIDS Eastman Chemical Company (US) 2009-11-25 EP claimed
EP-2118143-A1 REFORMATION OF IONIC LIQUIDS Eastman Chemical Company (US) 2009-11-18 EP claimed
EP-2118070-A1 PRODUCTION OF IONIC LIQUIDS Eastman Chemical Company (US) 2009-11-18 EP claimed
WO-2008100577-A1 PRODUCTION OF IONIC LIQUIDS EASTMAN CHEMICAL COMPANY (US) 2008-08-21 WO claimed
WO-2008100569-A1 REFORMATION OF IONIC LIQUIDS EASTMAN CHEMICAL COMPANY (US) 2008-08-21 WO claimed
WO-2008100566-A1 CELLULOSE ESTERS AND THEIR PRODUCTION IN CARBOXYLATED IONIC LIQUIDS EASTMAN CHEMICAL COMPANY (US) 2008-08-21 WO claimed
US-20080194834-A1 PRODUCTION OF IONIC LIQUIDS EASTMAN CHEMICAL COMPANY (US) 2008-08-14 US claimed
US-20080194808-A1 CELLULOSE ESTERS AND THEIR PRODUCTION IN CARBOXYLATED IONIC LIQUIDS EASTMAN CHEMICAL COMPANY (US) 2008-08-14 US claimed
US-20080194807-A1 REFORMATION OF IONIC LIQUIDS EASTMAN CHEMICAL COMPANY (US) 2008-08-14 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080194834-A1 PRODUCTION OF IONIC LIQUIDS GLUL, ICMT, ALAD ALDH1A1 491/4885NAAA 1429/4885CES2 1947/4885
US-20080194808-A1 CELLULOSE ESTERS AND THEIR PRODUCTION IN CARBOXYLATED IONIC LIQUIDS CEL, ACMSD, ACOT7 ALDH1A1 1073/4885NAAA 56/4885CES2 17/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.